In the Margins

United CEO's illness highlights boards' disclosure quandry

October 19, 2015

By The Wall Street Journal

Boards often wrestle with how and when to tell shareholders when a CEO is experiencing a disabling illness. Companies typically don't reveal a CEO's health problems until a condition reaches a critical stage, and the board of United Continental Holdings has been less than forthcoming following CEO Oscar Munoz's heart attack on Oct. 15. Read the original story from The Wall Street Journal

 

 

Most Read

A Seat at the Table
We've had A Seat at the Table — for 10 years

The very first independent chair we profiled for FBV was Leigh Wilson at Victory Funds, for our A Seat at the Table section. Victory Capital Management had recently redefined itself ...

Top of the Agenda - Governance
Fewer women, minorities among new fund directors

After years of making gains in filling fund board seats, women and individuals representing minority groups lost significant ground in the most recent two-year period measured ...